Breaking News Instant updates and real-time market news.

DTRUY

Daimler Truck

$18.06 /

-0.73 (-3.89%)

07:11
01/28/22
01/28
07:11
01/28/22
07:11

Daimler Truck Holding initiated with an Overweight at Morgan Stanley

Morgan Stanley analyst Harald Hendrikse initiated coverage of Daimler Truck Holding with an Overweight rating and EUR 38 price target. Daimler's Truck independence gives it an opportunity to improve returns and FY22 "likely looks solid, as with other more profitable Truck OEMs," Hendrikse said. At the current discounted valuation, downside risks seem priced in and "the value case is in place," but now Daimler Trucks "needs to execute," Hendrikse added.

OTHER BREAKING NEWS FROM THE FLY

General news
Treasury Market Summary: » 22:55
12/08/22
12/08
22:55
12/08/22
22:55
$ECON

Economic Data

/

+

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Nerdy to cut 17% of its workforce » 20:50
12/08/22
12/08
20:50
12/08/22
20:50
NRDY

Nerdy

$2.00 /

-0.035 (-1.72%)

In a regulatory 8-K…

In a regulatory 8-K filing, Nerdy states: "On December 8, 2022, Nerdy announced the completion of workforce reductions of approximately 17 % of the Company's total workforce. The reductions primarily affected variable hourly roles and included a limited number of corporate fixed personnel roles. The new products and go-to-market strategies in both the Company's Consumer and Institutional business categories, which focus on recurring revenue relationships with higher value customers, allow for a simplified sales model and generate operating efficiencies, including in the headcount needed to operate certain areas of the business. The Company does not expect any negative impact on its ability to meet the evolving needs of its customers, its ability to grow revenue, or its capacity for innovation as a result of these actions. These decisions, in combination with other cost-reduction measures, are intended to reduce operating expenses in support of the Company's stated goal to achieve adjusted-EBITDA profitability by the end of 2023, as previously communicated. The Company currently estimates that it will incur one-time charges in the fourth quarter of 2022 of approximately $1 million to $2 million in connection with the workforce reductions, primarily for severance payments and related employee benefit costs. The Company expects that the implementation of the headcount reductions, including cash payments, will be substantially complete by the end of the fourth quarter of 2022."

ShowHide Related Items >><<
NRDY Nerdy
$2.00 /

-0.035 (-1.72%)

NRDY Nerdy
$2.00 /

-0.035 (-1.72%)

12/07/22 Cantor Fitzgerald
Udemy named new 'top pick' in software at Cantor Fitzgerald
11/15/22 Canaccord
Nerdy price target lowered to $5 from $6 at Canaccord
10/18/22 Barclays
Nerdy price target lowered to $2.50 from $4 at Barclays
06/29/22 JPMorgan
Nerdy price target lowered to $6 from $7 at JPMorgan
NRDY Nerdy
$2.00 /

-0.035 (-1.72%)

NRDY Nerdy
$2.00 /

-0.035 (-1.72%)

Hot Stocks
Walgreens Boots Alliance sells $1.0B in AmerisourceBergen shares » 20:47
12/08/22
12/08
20:47
12/08/22
20:47
WBA

Walgreens Boots Alliance

$40.89 /

+0.24 (+0.59%)

, ABC

AmerisourceBergen

$170.46 /

+0.17 (+0.10%)

Walgreens Boots Alliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$40.89 /

+0.24 (+0.59%)

ABC AmerisourceBergen
$170.46 /

+0.17 (+0.10%)

WBA Walgreens Boots Alliance
$40.89 /

+0.24 (+0.59%)

11/23/22 Morgan Stanley
Walgreens Boots Alliance assumed with an Underweight at Morgan Stanley
11/22/22 Cowen
Walgreens upgraded to Outperform on services transition at Cowen
11/22/22 Cowen
Walgreens Boots Alliance upgraded to Outperform from Market Perform at Cowen
11/18/22 JPMorgan
Walgreens Boots Alliance upgraded to Overweight from Neutral at JPMorgan
ABC AmerisourceBergen
$170.46 /

+0.17 (+0.10%)

11/22/22 Credit Suisse
AmerisourceBergen price target raised to $182 from $175 at Credit Suisse
11/04/22 Baird
AmerisourceBergen price target raised to $195 from $188 at Baird
10/18/22 Cowen
AmerisourceBergen price target lowered to $169 from $170 at Cowen
10/11/22 BofA
BofA upgrades AmerisourceBergen to Buy, sees ongoing EBIT growth
WBA Walgreens Boots Alliance
$40.89 /

+0.24 (+0.59%)

ABC AmerisourceBergen
$170.46 /

+0.17 (+0.10%)

  • 08
    Nov
WBA Walgreens Boots Alliance
$40.89 /

+0.24 (+0.59%)

ABC AmerisourceBergen
$170.46 /

+0.17 (+0.10%)

WBA Walgreens Boots Alliance
$40.89 /

+0.24 (+0.59%)

ABC AmerisourceBergen
$170.46 /

+0.17 (+0.10%)

WBA Walgreens Boots Alliance
$40.89 /

+0.24 (+0.59%)

Syndicate
Prometheus 4.55M share Secondary priced at $110.00 » 20:04
12/08/22
12/08
20:04
12/08/22
20:04
RXDX

Prometheus

$117.34 /

+21.41 (+22.32%)

The deal size was…

The deal size was increased to $500M from $250M and priced below last closing price of $117.64. Goldman Sachs, SVB Securities, Jefferies and Guggenheim are acting as joint book running managers for the offering.

ShowHide Related Items >><<
RXDX Prometheus
$117.34 /

+21.41 (+22.32%)

RXDX Prometheus
$117.34 /

+21.41 (+22.32%)

09:12 Today RBC Capital
Prometheus price target raised to $111 from $66 at RBC Capital
07:13 Today Credit Suisse
Prometheus price target raised to $142 from $59 at Credit Suisse
07:11 Today Wells Fargo
Prometheus price target raised to $164 from $71 at Wells Fargo
06:17 Today BTIG
Prometheus price target raised to $181 from $74 at BTIG
RXDX Prometheus
$117.34 /

+21.41 (+22.32%)

  • 09
    Dec
RXDX Prometheus
$117.34 /

+21.41 (+22.32%)

RXDX Prometheus
$117.34 /

+21.41 (+22.32%)

Periodicals
United Airlines to announce large Boeing Dreamliner order, Reuters reports » 19:31
12/08/22
12/08
19:31
12/08/22
19:31
UAL

United Airlines

$42.80 /

-1.265 (-2.87%)

, BA

Boeing

$179.10 /

+2.6 (+1.47%)

United Airlines (UAL)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UAL United Airlines
$42.80 /

-1.265 (-2.87%)

BA Boeing
$179.10 /

+2.6 (+1.47%)

UAL United Airlines
$42.80 /

-1.265 (-2.87%)

12/06/22 Argus
United Airlines upgraded to Buy at Argus amid recovering air travel demand
12/06/22 Argus
United Airlines upgraded to Buy from Hold at Argus
12/05/22 Morgan Stanley
United Airlines upgraded to Overweight from Equal Weight at Morgan Stanley
10/25/22 Cowen
Mesa Air price target lowered to $1.50 from $4.00 at Cowen
BA Boeing
$179.10 /

+2.6 (+1.47%)

07:03 Today Wells Fargo
Boeing price target raised to $218 from $185 at Wells Fargo
06:12 Today Citi
Boeing assumed with a Buy at Citi
12/07/22 BofA
Boeing price target raised to $190 from $165 at BofA
12/06/22 Morgan Stanley
Textron's FLRAA win should be 'positively received,' says Morgan Stanley
UAL United Airlines
$42.80 /

-1.265 (-2.87%)

BA Boeing
$179.10 /

+2.6 (+1.47%)

UAL United Airlines
$42.80 /

-1.265 (-2.87%)

BA Boeing
$179.10 /

+2.6 (+1.47%)

UAL United Airlines
$42.80 /

-1.265 (-2.87%)

BA Boeing
$179.10 /

+2.6 (+1.47%)

UAL United Airlines
$42.80 /

-1.265 (-2.87%)

BA Boeing
$179.10 /

+2.6 (+1.47%)

Hot Stocks
Myriad Genetics presents results validating RiskScore in breast cancer detection » 19:18
12/08/22
12/08
19:18
12/08/22
19:18
MYGN

Myriad Genetics

$19.48 /

-0.12 (-0.61%)

The company states:…

The company states: "Myriad Genetics presented results from a longitudinal study validating RiskScore as a well-calibrated and more accurate predictor of breast cancer risk than a standard-of-care risk assessment alone. The data was shared in a spotlight discussion at the 2022 San Antonio Breast Cancer Symposium. Working with industry-leading researchers, Myriad Genetics studied outcomes from more than 130,000 women who received RiskScore results. By analyzing data on whether women developed breast cancer after their initial test result, the study demonstrated that RiskScore was more accurate at stratifying women at high- or low-risk of developing breast cancer than a standard of care risk assessment method. Based on these findings, clinical use of RiskScore may lead to improved breast cancer prevention and screening strategies."

ShowHide Related Items >><<
MYGN Myriad Genetics
$19.48 /

-0.12 (-0.61%)

MYGN Myriad Genetics
$19.48 /

-0.12 (-0.61%)

10/05/22 Stephens
Stephens starts Myriad Genetics at Equal Weight, sees stock as 'show me story'
10/05/22 Stephens
Myriad Genetics initiated with an Equal Weight at Stephens
MYGN Myriad Genetics
$19.48 /

-0.12 (-0.61%)

Syndicate
Grom Social Enterprises prices $5.0M public offering » 18:51
12/08/22
12/08
18:51
12/08/22
18:51
GROM

Grom Social Enterprises

/

+

Grom Social Enterprises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GROM Grom Social Enterprises
/

+

GROM Grom Social Enterprises
/

+

07/26/22 EF Hutton
Grom Social price target lowered to $2 from $5 at EF Hutton
01/13/22 EF Hutton
Grom Social Enterprises initiated with a Buy at EF Hutton
Hot Stocks
Black Stone Minerals CEO buys $839K in common stock » 18:47
12/08/22
12/08
18:47
12/08/22
18:47
BSM

Black Stone Minerals

$16.86 /

-0.395 (-2.29%)

In a regulatory filing,…

In a regulatory filing, Black Stone Minerals disclosed that its CEO Thomas Carter bought 48.5K share of common stock on December 6 in a total transaction size of $839K.

ShowHide Related Items >><<
BSM Black Stone Minerals
$16.86 /

-0.395 (-2.29%)

BSM Black Stone Minerals
$16.86 /

-0.395 (-2.29%)

11/17/22 Piper Sandler
Black Stone Minerals price target raised to $19 from $18 at Piper Sandler
10/18/22 Piper Sandler
Black Stone Minerals price target raised to $18 from $17 at Piper Sandler
09/19/22 KeyBanc
KeyBanc starts Black Stone with Overweight, sees 'inflection point'
09/19/22 KeyBanc
Black Stone Minerals initiated with an Overweight at KeyBanc
BSM Black Stone Minerals
$16.86 /

-0.395 (-2.29%)

BSM Black Stone Minerals
$16.86 /

-0.395 (-2.29%)

Hot Stocks
Veeva director sells $1.64M in common stock » 18:46
12/08/22
12/08
18:46
12/08/22
18:46
VEEV

Veeva

$173.37 /

+8.14 (+4.93%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VEEV Veeva
$173.37 /

+8.14 (+4.93%)

VEEV Veeva
$173.37 /

+8.14 (+4.93%)

12/06/22 Cowen
Veeva initiated with a Market Perform at Cowen
12/05/22 KeyBanc
Veeva price target lowered to $210 from $220 at KeyBanc
12/05/22 Citi
Salesforce price target lowered to $164 from $170 at Citi
12/02/22 Morgan Stanley
Veeva assumed with an Equal Weight at Morgan Stanley
VEEV Veeva
$173.37 /

+8.14 (+4.93%)

VEEV Veeva
$173.37 /

+8.14 (+4.93%)

VEEV Veeva
$173.37 /

+8.14 (+4.93%)

Hot Stocks
Douglas Emmett cuts quarterly cash dividend to 19c per share from 28c » 18:45
12/08/22
12/08
18:45
12/08/22
18:45
DEI

Douglas Emmett

$15.39 /

+0.155 (+1.02%)

Douglas Emmett announced…

Douglas Emmett announced that its Board of Directors has declared a quarterly cash dividend on each share of its common stock of 19c, or 76c on an annualized basis, to be paid on January 18, 2023 to shareholders of record as of December 30, 2022. This represents a reduction from the Company's previous quarterly dividend of 28c per common share, which was paid on October 18, 2022. The new dividend rate will provide the company with more than $74M per year in additional liquidity. This further reinforces Douglas Emmett's already strong financial position and enhances the company's ability to take advantage of compelling opportunities as they arise.

ShowHide Related Items >><<
DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

10/07/22 Piper Sandler
Douglas Emmett downgraded to Neutral from Overweight at Piper Sandler
09/27/22 Evercore ISI
Douglas Emmett downgraded to In Line from Outperform at Evercore ISI
06/30/22 Jefferies
Douglas Emmett price target lowered to $24 from $31 at Jefferies
06/22/22 Credit Suisse
Douglas Emmett initiated with an Outperform at Credit Suisse
DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

Periodicals
Walmart to back Buy-Now-Pay-Later loan fintech venture, The Information reports » 18:45
12/08/22
12/08
18:45
12/08/22
18:45
WMT

Walmart

$148.79 /

+0.26 (+0.18%)

, AFRM

Affirm

$11.63 /

+0.285 (+2.51%)

, AAPL

Apple

$142.66 /

+1.7 (+1.21%)

Walmart (WMT) backed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

WMT Walmart
$148.79 /

+0.26 (+0.18%)

12/06/22 Bernstein
Walmart initiated with a Market Perform at Bernstein
12/01/22 Atlantic Equities
Walmart price target raised to $165 from $150 at Atlantic Equities
11/18/22 Gordon Haskett
Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner
11/17/22 Truist
Target price target lowered to $151 from $165 at Truist
AFRM Affirm
$11.63 /

+0.285 (+2.51%)

07:46 Today Morgan Stanley
Block price target lowered to $66 from $67 at Morgan Stanley
07:46 Today Morgan Stanley
Affirm price target lowered to $46 from $52 at Morgan Stanley
11/29/22 UBS
Affirm initiated with a Neutral at UBS
11/10/22 DA Davidson
Affirm price target lowered to $32 from $50 at DA Davidson
AAPL Apple
$142.66 /

+1.7 (+1.21%)

12/07/22 Morgan Stanley
Morgan Stanley 'incrementally more conservative' on Apple's December quarter
12/06/22 UBS
Apple iPhone 14 Pro/Pro Max delivery times finally easing, says UBS
12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

WMT Walmart
$148.79 /

+0.26 (+0.18%)

AFRM Affirm
$11.63 /

+0.285 (+2.51%)

AAPL Apple
$142.66 /

+1.7 (+1.21%)

Hot Stocks
Douglas Emmett announces $300M share repurchase authorization » 18:44
12/08/22
12/08
18:44
12/08/22
18:44
DEI

Douglas Emmett

$15.39 /

+0.155 (+1.02%)

Douglas Emmett announced…

Douglas Emmett announced that its Board of Directors has authorized the repurchase of up to $300M of its outstanding common shares under a newly established share repurchase program.

ShowHide Related Items >><<
DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

10/07/22 Piper Sandler
Douglas Emmett downgraded to Neutral from Overweight at Piper Sandler
09/27/22 Evercore ISI
Douglas Emmett downgraded to In Line from Outperform at Evercore ISI
06/30/22 Jefferies
Douglas Emmett price target lowered to $24 from $31 at Jefferies
06/22/22 Credit Suisse
Douglas Emmett initiated with an Outperform at Credit Suisse
DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

DEI Douglas Emmett
$15.39 /

+0.155 (+1.02%)

Hot Stocks
Salesforce CEO: Planning for CRM to be second largest software company » 18:27
12/08/22
12/08
18:27
12/08/22
18:27
CRM

Salesforce

$130.16 /

-0.2848 (-0.22%)

In an interview on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

06:25 Today Baird
Baird downgrades Salesforce on macro, executive turnover concerns
05:29 Today Baird
Salesforce downgraded to Neutral from Outperform at Baird
12/05/22 KeyBanc
Veeva price target lowered to $210 from $220 at KeyBanc
12/05/22 Credit Suisse
Salesforce price target lowered to $225 from $250 at Credit Suisse
CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

CRM Salesforce
$130.16 /

-0.2848 (-0.22%)

On The Fly
Fly Intel: After-Hours Movers » 18:00
12/08/22
12/08
18:00
12/08/22
18:00
DOCU

DocuSign

$43.78 /

+1.73 (+4.11%)

, AVGO

Broadcom

$531.27 /

+12.72 (+2.45%)

, PHR

Phreesia

$26.67 /

+0.7 (+2.70%)

, RH

RH

$266.37 /

+4.545 (+1.74%)

, MTN

Vail Resorts

$251.07 /

+4.69 (+1.90%)

, BBWI

Bath & Body Works

$42.16 /

-0.85 (-1.98%)

, JAZZ

Jazz Pharmaceuticals

$150.28 /

-0.93 (-0.62%)

, CURV

Torrid

$4.29 /

+0.385 (+9.86%)

, LULU

Lululemon

$375.51 /

+2.84 (+0.76%)

, CHWY

Chewy

$41.98 /

+0.77 (+1.87%)

, IOVA

Iovance Biotherapeutics

$7.17 /

-0.085 (-1.17%)

Check out this evening's…

ShowHide Related Items >><<
RH RH
$266.37 /

+4.545 (+1.74%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

12/06/22 Citi
DocuSign price target lowered to $59 from $76 at Citi
12/05/22 UBS
DocuSign price target lowered to $52 from $65 at UBS
12/05/22 Baird
DocuSign price target lowered to $50 from $70 at Baird
11/30/22 Jefferies
DocuSign initiated with a Hold at Jefferies
AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

12/05/22 Susquehanna
Broadcom price target lowered to $650 from $680 at Susquehanna
12/05/22 Piper Sandler
Broadcom price target lowered to $715 from $750 at Piper Sandler
10/27/22 Jefferies
Meta commentary positive for datacenter semi names, says Jefferies
10/18/22 Deutsche Bank
Broadcom price target lowered to $575 from $635 at Deutsche Bank
PHR Phreesia
$26.67 /

+0.7 (+2.70%)

10/13/22 DA Davidson
Phreesia initiated at Neutral at DA Davidson yesterday on valuation
10/12/22 DA Davidson
Phreesia initiated with a Neutral at DA Davidson
09/15/22 KeyBanc
Phreesia initiated with an Overweight at KeyBanc
09/08/22 Piper Sandler
Piper Sandler ups Phreesia price target to $33 following 'strong' Q2 beat
RH RH
$266.37 /

+4.545 (+1.74%)

11/21/22 Barclays
RH downgraded to Equal Weight from Overweight at Barclays
11/18/22 Wedbush
Wedbush downgrades RH on 'course-correction,' deteriorating macro
11/18/22 Wedbush
RH downgraded to Neutral from Outperform at Wedbush
10/31/22 Citi
RH price target lowered to $305 from $338 at Citi
MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

09/29/22 Truist
Vail Resorts price target lowered to $270 from $281 at Truist
09/29/22 Deutsche Bank
Vail Resorts price target lowered to $283 from $286 at Deutsche Bank
09/29/22 Barclays
Vail Resorts price target raised to $224 from $217 at Barclays
09/26/22 Stifel
Vail Resorts price target lowered to $228 from $273 at Stifel
BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

12/07/22 Argus
Bath & Body Works price target raised to $50 from $45 at Argus
11/28/22 Goldman Sachs
Goldman finds small crowds, more promotions over Black Friday weekend
11/18/22 Citi
Bath & Body Works price target raised to $50 from $48 at Citi
11/17/22 Morgan Stanley
Bath & Body Works price target raised to $76 from $72 at Morgan Stanley
JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

17:42 Today Goldman Sachs
Jazz Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
11/30/22 Jefferies
Avadel upgraded to Buy at Jefferies after survey of sleep doctors
11/21/22 Needham
Avadel Pharmaceuticals price target raised to $9 from $8 at Needham
11/01/22 H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
CURV Torrid
$4.29 /

+0.385 (+9.86%)

09/22/22 Morgan Stanley
Torrid price target lowered to $5 from $6.50 at Morgan Stanley
08/04/22 Baird
Torrid price target lowered to $7 from $9 at Baird
07/21/22 Goldman Sachs
Torrid price target lowered to $4 from $5.50 at Goldman Sachs
07/15/22 Cowen
Torrid downgraded to Market Perform at Cowen on low income consumer exposure
LULU Lululemon
$375.51 /

+2.84 (+0.76%)

12/07/22 Deutsche Bank
Lululemon price target raised to $450 from $434 at Deutsche Bank
12/06/22 Raymond James
Lululemon price target raised to $438 from $345 at Raymond James
12/05/22 Stifel
Lululemon price target raised to $450 from $400 at Stifel
12/05/22 Cowen
Lululemon price target raised to $542 from $535 at Cowen
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/21/22 Deutsche Bank
Chewy price target raised to $50 from $40 at Deutsche Bank
11/15/22 MoffettNathanson
Chewy initiated with a Market Perform at MoffettNathanson
IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

17:09 Today Goldman Sachs
Iovance Biotherapeutics downgraded to Neutral from Buy at Goldman Sachs
11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
RH RH
$266.37 /

+4.545 (+1.74%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

RH RH
$266.37 /

+4.545 (+1.74%)

PHR Phreesia
$26.67 /

+0.7 (+2.70%)

MTN Vail Resorts
$251.07 /

+4.69 (+1.90%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

RH RH
$266.37 /

+4.545 (+1.74%)

LULU Lululemon
$375.51 /

+2.84 (+0.76%)

IOVA Iovance Biotherapeutics
$7.17 /

-0.085 (-1.17%)

DOCU DocuSign
$43.78 /

+1.73 (+4.11%)

CURV Torrid
$4.29 /

+0.385 (+9.86%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

BBWI Bath & Body Works
$42.16 /

-0.85 (-1.98%)

AVGO Broadcom
$531.27 /

+12.72 (+2.45%)

Periodicals
NHTSA seeks info on potentially defective air-bag inflators, WSJ reports » 17:54
12/08/22
12/08
17:54
12/08/22
17:54
F

Ford

$13.13 /

+0.015 (+0.11%)

, GM

General Motors

$38.21 /

+0.28 (+0.74%)

, HMC

Honda

$23.89 /

+0.02 (+0.08%)

, NSANY

Nissan

$6.82 /

+0.015 (+0.22%)

, TM

Toyota

$142.22 /

+0.52 (+0.37%)

, TSLA

Tesla

$173.44 /

-0.68 (-0.39%)

, DDAIF

Mercedes-Benz Group

/

+

, VWAGY

Volkswagen

$18.66 /

-0.18 (-0.96%)

, STLA

Stellantis

$14.85 /

-0.375 (-2.46%)

The U.S. National Highway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

TM Toyota
$142.22 /

+0.52 (+0.37%)

STLA Stellantis
$14.85 /

-0.375 (-2.46%)

NSANY Nissan
$6.82 /

+0.015 (+0.22%)

HMC Honda
$23.89 /

+0.02 (+0.08%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

F Ford
$13.13 /

+0.015 (+0.11%)

DDAIF Mercedes-Benz Group
/

+

F Ford
$13.13 /

+0.015 (+0.11%)

12/05/22 Jefferies
Fox Factory price target raised to $135 from $120 at Jefferies
12/05/22 Jefferies
Polaris price target raised to $106 from $100 at Jefferies
11/30/22 Citi
Ford price target raised to $14 from $13 at Citi
10/27/22 Morgan Stanley
Ford decision to wind down Argo a positive, says Morgan Stanley
GM General Motors
$38.21 /

+0.28 (+0.74%)

11/18/22 Wedbush
GM's Investor Day event 'impressive,' says Wedbush
11/10/22 Wolfe Research
General Motors downgraded to Peer Perform from Outperform at Wolfe Research
10/26/22 Deutsche Bank
General Motors price target lowered to $35 from $36 at Deutsche Bank
10/26/22 JPMorgan
General Motors price target raised to $59 from $58 at JPMorgan
HMC Honda
$23.89 /

+0.02 (+0.08%)

03/03/22 Morgan Stanley
Other legacy automakers may follow Ford's lead, says Morgan Stanley
12/28/21 BofA
BofA sees December U.S. light vehicle sales down 20%
NSANY Nissan
$6.82 /

+0.015 (+0.22%)

11/28/22 JPMorgan
Nissan downgraded to Neutral from Overweight at JPMorgan
04/25/22 Citi
Nissan collaboration 'clear positive' for Luminar, says Citi
12/15/21 JPMorgan
Nissan upgraded to Overweight from Neutral at JPMorgan
TM Toyota
$142.22 /

+0.52 (+0.37%)

10/13/22 Citi
Toyota downgraded to Neutral at Citi on lower earnings outlook
10/13/22 Citi
Toyota downgraded to Neutral from Buy at Citi
10/06/22 UBS
Toyota downgraded to Neutral at UBS on lower profit forecasts
10/06/22 UBS
Toyota downgraded to Neutral from Buy at UBS
TSLA Tesla
$173.44 /

-0.68 (-0.39%)

13:21 Today Piper Sandler
Piper says Shanghai Gigafactory rumors 'easier to understand' amid weak November
12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
DDAIF Mercedes-Benz Group
/

+

07/29/22 RBC Capital
Mercedes-Benz Group price target raised to EUR 90 from EUR 89 at RBC Capital
07/07/22 UBS
Mercedes-Benz Group price target lowered to EUR 80 from EUR 90 at UBS
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
05/17/22 Bernstein
Mercedes-Benz Group initiated with an Outperform at Bernstein
VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

05:54 Today Exane BNP Paribas
Volkswagen downgraded to Underperform from Neutral at Exane BNP Paribas
12/07/22 Morgan Stanley
Volkswagen resumed with an Equal Weight at Morgan Stanley
11/08/22 BofA
Volkswagen upgraded to Buy from Neutral at BofA
11/08/22 Goldman Sachs
Volkswagen reinstated with a Neutral at Goldman Sachs
STLA Stellantis
$14.85 /

-0.375 (-2.46%)

11/30/22 Jefferies
Rio Tinto added to 'Franchise Picks' list at Jefferies
10/20/22 Nomura
Stellantis upgraded to Buy at Nomura amid 'appropriately paced' EV rollout
10/20/22 Nomura
Stellantis upgraded to Buy from Neutral at Nomura
10/14/22 Berenberg
Stellantis price target lowered to EUR 19 from EUR 21 at Berenberg
VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

TM Toyota
$142.22 /

+0.52 (+0.37%)

STLA Stellantis
$14.85 /

-0.375 (-2.46%)

HMC Honda
$23.89 /

+0.02 (+0.08%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

F Ford
$13.13 /

+0.015 (+0.11%)

DDAIF Mercedes-Benz Group
/

+

VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

TM Toyota
$142.22 /

+0.52 (+0.37%)

STLA Stellantis
$14.85 /

-0.375 (-2.46%)

NSANY Nissan
$6.82 /

+0.015 (+0.22%)

HMC Honda
$23.89 /

+0.02 (+0.08%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

F Ford
$13.13 /

+0.015 (+0.11%)

DDAIF Mercedes-Benz Group
/

+

VWAGY Volkswagen
$18.66 /

-0.18 (-0.96%)

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

TM Toyota
$142.22 /

+0.52 (+0.37%)

STLA Stellantis
$14.85 /

-0.375 (-2.46%)

NSANY Nissan
$6.82 /

+0.015 (+0.22%)

HMC Honda
$23.89 /

+0.02 (+0.08%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

F Ford
$13.13 /

+0.015 (+0.11%)

DDAIF Mercedes-Benz Group
/

+

TSLA Tesla
$173.44 /

-0.68 (-0.39%)

GM General Motors
$38.21 /

+0.28 (+0.74%)

F Ford
$13.13 /

+0.015 (+0.11%)

Recommendations
Rapt Therapeutics price target lowered to $33 from $34 at Piper Sandler » 17:48
12/08/22
12/08
17:48
12/08/22
17:48
RAPT

Rapt Therapeutics

$16.48 /

-0.31 (-1.85%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff lowered the firm's price target on Rapt Therapeutics to $33 from $34 and keeps an Overweight rating on the shares. The analyst anticipates more FLX-475 data in 2023, noting that Rapt is conducting the 16-week Phase IIb trial of RPT193 in moderate-to-severe atopic dermatitis patients with data in 2H23. Tenthoff noted he is trimming his price target to account for dilution from the recent financing.

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$16.48 /

-0.31 (-1.85%)

RAPT Rapt Therapeutics
$16.48 /

-0.31 (-1.85%)

12/01/22 Goldman Sachs
Rapt Therapeutics initiated with a Buy at Goldman Sachs
11/14/22 H.C. Wainwright
Rapt Therapeutics price target lowered to $50 from $53 at H.C. Wainwright
11/10/22 Piper Sandler
Rapt Therapeutics price target raised to $34 from $30 at Piper Sandler
09/21/22 Capital One
Capital One starts Rapt with Overweight, sees 100% upside
RAPT Rapt Therapeutics
$16.48 /

-0.31 (-1.85%)

  • 18
    Nov
RAPT Rapt Therapeutics
$16.48 /

-0.31 (-1.85%)

Upgrade
Jazz Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs » 17:42
12/08/22
12/08
17:42
12/08/22
17:42
JAZZ

Jazz Pharmaceuticals

$150.28 /

-0.93 (-0.62%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

11/30/22 Jefferies
Avadel upgraded to Buy at Jefferies after survey of sleep doctors
11/21/22 Needham
Avadel Pharmaceuticals price target raised to $9 from $8 at Needham
11/01/22 H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
10/24/22 Stifel
Zymeworks price target lowered to $18 from $21 at Stifel
JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

JAZZ Jazz Pharmaceuticals
$150.28 /

-0.93 (-0.62%)

Syndicate
Faraday Future files to sell 84.2M shares of common stock for holders  17:35
12/08/22
12/08
17:35
12/08/22
17:35
FFIE

Faraday Future

/

+

 
ShowHide Related Items >><<
FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

08/16/22 Benchmark
Faraday Future downgraded to Speculative Hold from Buy at Benchmark
FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

FFIE Faraday Future
/

+

Hot Stocks
Chewy says now expects FY22 capex to come in slightly below 2.5% of sales » 17:35
12/08/22
12/08
17:35
12/08/22
17:35
CHWY

Chewy

$41.98 /

+0.77 (+1.87%)

Says ended the third…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

12/07/22 Wolfe Research
Chewy downgraded to Peer Perform from Outperform at Wolfe Research
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/21/22 Deutsche Bank
Chewy price target raised to $50 from $40 at Deutsche Bank
11/15/22 MoffettNathanson
Chewy initiated with a Market Perform at MoffettNathanson
CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

CHWY Chewy
$41.98 /

+0.77 (+1.87%)

Hot Stocks
Airbus awarded $297.48M Army contract modification » 17:34
12/08/22
12/08
17:34
12/08/22
17:34
EADSY

Airbus

$29.04 /

+0.67 (+2.36%)

Airbus was awarded a…

Airbus was awarded a $297.48M modification to a contract for UH-72 Lakota contractor logistics support and engineering services. Work has an estimated completion date of December 31, 2023. FY23 operation and maintenance, Army funds in the amount of $76.38M were obligated at the time of the award. U.S. Army Contracting Command, Redstone Arsenal, Alabama, is the contracting activity.

ShowHide Related Items >><<
EADSY Airbus
$29.04 /

+0.67 (+2.36%)

EADSY Airbus
$29.04 /

+0.67 (+2.36%)

12/07/22 Kepler Cheuvreux
Airbus downgraded to Hold from Buy at Kepler Cheuvreux
12/06/22 Jefferies
Airbus price target lowered to EUR 132 from EUR 140 at Jefferies
11/07/22 Redburn
Safran initiated with a Buy at Redburn
11/07/22 Redburn
Airbus initiated with a Buy at Redburn
EADSY Airbus
$29.04 /

+0.67 (+2.36%)

EADSY Airbus
$29.04 /

+0.67 (+2.36%)

EADSY Airbus
$29.04 /

+0.67 (+2.36%)

Hot Stocks
Lockheed Martin awarded $328.53M Navy contract modification » 17:33
12/08/22
12/08
17:33
12/08/22
17:33
LMT

Lockheed Martin

$485.24 /

+3.89 (+0.81%)

Lockheed Martin was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

06:16 Today Citi
Lockheed Martin initiated with a Buy at Citi
12/06/22 Morgan Stanley
Textron's FLRAA win should be 'positively received,' says Morgan Stanley
12/05/22 Jefferies
Textron award estimated at $11 per share net present value, says Jefferies
12/05/22 Jefferies
Lockheed Martin price target raised to $525 from $500 at Jefferies
LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

Hot Stocks
Lockheed Martin awarded $2.22B Navy contract modification » 17:30
12/08/22
12/08
17:30
12/08/22
17:30
LMT

Lockheed Martin

$485.24 /

+3.89 (+0.81%)

Lockheed Martin was…

Lockheed Martin was awarded a $2.22B cost-plus-fixed-fee, cost-plus-incentive-fee, firm-fixed-price, and fixed-price incentive, cost reimbursable modification to a previously awarded contract. This modification exercises an option to provide logistics support, to include ground maintenance activities, action request solution, depot activities, automatic logistics information system operations and maintenance, reliability and maintainability, supply chain management, pilot training, maintainer training, and training system sustainment in support of delivered F-35 Lightning II Joint Strike Fighter air systems for the Air Force, Marine Corps, Navy, Foreign Military Sales (FMS) customers, and non-Department of Defense (DOD) participants. Work is expected to be completed in December 2023. The Naval Air Systems Command, Patuxent River, Maryland, is the contracting activity.

ShowHide Related Items >><<
LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

06:16 Today Citi
Lockheed Martin initiated with a Buy at Citi
12/06/22 Morgan Stanley
Textron's FLRAA win should be 'positively received,' says Morgan Stanley
12/05/22 Jefferies
Textron award estimated at $11 per share net present value, says Jefferies
12/05/22 Jefferies
Lockheed Martin price target raised to $525 from $500 at Jefferies
LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

LMT Lockheed Martin
$485.24 /

+3.89 (+0.81%)

Periodicals
Microsoft says Riot Games content coming to Game Pass December 12 » 17:25
12/08/22
12/08
17:25
12/08/22
17:25
MSFT

Microsoft

$247.41 /

+3.07 (+1.26%)

, TCEHY

Tencent

$40.88 /

+1.69 (+4.31%)

Microsoft (MSFT)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCEHY Tencent
$40.88 /

+1.69 (+4.31%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

06:56 Today Citi
DoD contracts shows competitiveness of cloud industry, says Citi
12/07/22 BTIG
SentinelOne price target lowered to $20 from $25 at BTIG
12/01/22 BMO Capital
Okta price target raised to $69 from $58 at BMO Capital
12/01/22 Wedbush
Activision Blizzard added to Best Ideas List at Wedbush
TCEHY Tencent
$40.88 /

+1.69 (+4.31%)

11/02/22 Morgan Stanley
Tencent named a 'Catalyst Driven Idea' at Morgan Stanley
10/28/22 Barclays
Tencent price target lowered to $31 from $44 at Barclays
10/24/22 KGI Securities
Tencent downgraded to Neutral from Outperform at KGI Securities
09/22/22 Stifel
Ubisoft downgraded to Hold from Buy at Stifel
MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

TCEHY Tencent
$40.88 /

+1.69 (+4.31%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

TCEHY Tencent
$40.88 /

+1.69 (+4.31%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

MSFT Microsoft
$247.41 /

+3.07 (+1.26%)

Conference/Events
Cantor Fitzgerald pharma/biotech analysts hold a dinner » 17:25
12/08/22
12/08
17:25
12/08/22
17:25
APLS

Apellis

$50.25 /

+2.575 (+5.40%)

, ISEE

Iveric bio

$21.23 /

+0.35 (+1.68%)

, JNJ

Johnson & Johnson

$177.19 /

-0.06 (-0.03%)

, NVS

Novartis

$91.58 /

-0.16 (-0.17%)

, AKTX

Akari Therapeutics

/

+

, BLTE

Belite Bio

$31.11 /

+0.705 (+2.32%)

, LCTX

Lineage Cell Therapeutics

$1.26 /

-0.05 (-3.82%)

, OCGN

Ocugen

$1.41 /

+0.035 (+2.55%)

, REGN

Regeneron

$765.12 /

+0.95 (+0.12%)

, RHHBY

Roche

$40.47 /

+0.52 (+1.30%)

, EYPT

EyePoint

$3.04 /

-0.005 (-0.16%)

, OCUL

Ocular Therapeutix

$2.76 /

-0.04 (-1.43%)

, CLSD

Clearside Biomedical

$1.16 /

+ (+0.00%)

, FDMT

4D Molecular

$24.51 /

+2.94 (+13.63%)

In conjunction with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$40.47 /

+0.52 (+1.30%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

OCUL Ocular Therapeutix
$2.76 /

-0.04 (-1.43%)

OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

LCTX Lineage Cell Therapeutics
$1.26 /

-0.05 (-3.82%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

FDMT 4D Molecular
$24.51 /

+2.94 (+13.63%)

EYPT EyePoint
$3.04 /

-0.005 (-0.16%)

CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

BLTE Belite Bio
$31.11 /

+0.705 (+2.32%)

APLS Apellis
$50.25 /

+2.575 (+5.40%)

AKTX Akari Therapeutics
/

+

APLS Apellis
$50.25 /

+2.575 (+5.40%)

11/18/22 Cowen
Apellis should trade to $70 upon pegectacoplan approval, says Cowen
11/10/22 Jefferies
Apellis downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Apellis downgraded to Hold from Buy at Jefferies
ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

11/10/22 Jefferies
Iveric bio downgraded to Hold from Buy at Jefferies
10/17/22 B. Riley
Iveric bio upgraded to Neutral at B. Riley after competitor in GA 'disappoints'
JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

12/07/22 Piper Sandler
Horizon Therapeutics price target raised to $110 from $90 at Piper Sandler
12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
NVS Novartis
$91.58 /

-0.16 (-0.17%)

12/05/22 Stifel
Novartis upgraded to Buy from Hold at Stifel
10/26/22 JPMorgan
Novartis price target lowered to CHF 78 from CHF 81 at JPMorgan
10/14/22 Barclays
Novartis price target lowered to CHF 75 from CHF 85 at Barclays
10/07/22 Deutsche Bank
Novartis price target lowered to CHF 70 from CHF 75 at Deutsche Bank
AKTX Akari Therapeutics
/

+

12/05/22 H.C. Wainwright
Akari Therapeutics initiated with a Buy at H.C. Wainwright
11/01/22 Alliance Global Partners
Akari Therapeutics initiated with a Buy at Alliance Global Partners
BLTE Belite Bio
$31.11 /

+0.705 (+2.32%)

08/01/22 H.C. Wainwright
Belite Bio initiated with a Buy at H.C. Wainwright
07/01/22 Benchmark
Belite Bio initiated with a Buy at Benchmark
LCTX Lineage Cell Therapeutics
$1.26 /

-0.05 (-3.82%)

11/01/22 Baird
Baird starts Lineage Cell Therapeutics with an Outperform, $5 price target
11/01/22 Baird
Lineage Cell Therapeutics initiated with an Outperform at Baird
06/14/22 B. Riley
B. Riley starts 'deep value play' Lineage Cell with Buy, $4 target
06/14/22 B. Riley
Lineage Cell Therapeutics initiated with a Buy at B. Riley
OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

08/23/22 Mizuho
Ocugen initiated with a Buy at Mizuho
08/15/22 H.C. Wainwright
Ocugen price target lowered to $6 from $7 at H.C. Wainwright
06/15/22 Roth Capital
Ocugen resumed at Buy at Roth Capital on COVAXIN and OCU400 potential
06/15/22 Roth Capital
Ocugen resumed at Buy from Neutral at Roth Capital
REGN Regeneron
$765.12 /

+0.95 (+0.12%)

11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/09/22 Truist
Regeneron price target raised to $856 from $790 at Truist
11/03/22 Piper Sandler
Regeneron price target lowered to $765 from $775 at Piper Sandler
10/31/22 EF Hutton
Regeneron initiated with a Buy at EF Hutton
RHHBY Roche
$40.47 /

+0.52 (+1.30%)

12/07/22 Morgan Stanley
Roche price target lowered to CHF 330 from CHF 350 at Morgan Stanley
12/02/22 BofA
Hookipa Pharma downgraded to Underperform from Buy at BofA
11/29/22 Guggenheim
Roche bladder cancer indication withdrawal positive for Seagen, says Guggenheim
11/15/22 Truist
Biogen price target raised to $350 from $265 at Truist
EYPT EyePoint
$3.04 /

-0.005 (-0.16%)

08/31/22 Cantor Fitzgerald
Cantor says EyePoint negative stock reaction to 8-K 'overdone'
08/04/22 H.C. Wainwright
EyePoint price target raised to $25 from $24 at H.C. Wainwright
07/07/22 Chardan
EyePoint initiated with a Buy at Chardan
OCUL Ocular Therapeutix
$2.76 /

-0.04 (-1.43%)

11/08/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $9 from $10 at H.C. Wainwright
11/08/22 Raymond James
Ocular Therapeutix price target lowered to $14 from $29 at Raymond James
09/29/22 Piper Sandler
Ocular Therapeutix data 'paint a compelling profile,' says Piper Sandler
09/27/22 Piper Sandler
Ocular Therapeutix hit/beat on Phase I study expectations, says Piper Sandler
CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

11/10/22 Needham
Clearside Biomedical upgraded to Buy from Hold at Needham
11/10/22 H.C. Wainwright
Clearside Biomedical price target raised to $6 from $5 at H.C. Wainwright
11/09/22 Stifel
Clearside Biomedical upgraded to Buy at Stifel after positive trial readout
11/09/22 Stifel
Clearside Biomedical upgraded to Buy from Hold at Stifel
FDMT 4D Molecular
$24.51 /

+2.94 (+13.63%)

11/18/22 H.C. Wainwright
4D Molecular initiated with a Buy at H.C. Wainwright
11/15/22 Goldman Sachs
4D Molecular upgraded to Buy from Neutral at Goldman Sachs
11/14/22 BofA
4D Molecular price target raised to $25 from $15 at BofA
11/14/22 Evercore ISI
4D Molecular price target raised to $45 from $32 at Evercore ISI
RHHBY Roche
$40.47 /

+0.52 (+1.30%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

OCUL Ocular Therapeutix
$2.76 /

-0.04 (-1.43%)

OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

LCTX Lineage Cell Therapeutics
$1.26 /

-0.05 (-3.82%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

FDMT 4D Molecular
$24.51 /

+2.94 (+13.63%)

EYPT EyePoint
$3.04 /

-0.005 (-0.16%)

CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

AKTX Akari Therapeutics
/

+

  • 01
    Dec
  • 29
    Apr
  • 24
    Mar
  • 23
    Feb
REGN Regeneron
$765.12 /

+0.95 (+0.12%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

RHHBY Roche
$40.47 /

+0.52 (+1.30%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

OCUL Ocular Therapeutix
$2.76 /

-0.04 (-1.43%)

OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

LCTX Lineage Cell Therapeutics
$1.26 /

-0.05 (-3.82%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

FDMT 4D Molecular
$24.51 /

+2.94 (+13.63%)

BLTE Belite Bio
$31.11 /

+0.705 (+2.32%)

APLS Apellis
$50.25 /

+2.575 (+5.40%)

REGN Regeneron
$765.12 /

+0.95 (+0.12%)

OCGN Ocugen
$1.41 /

+0.035 (+2.55%)

NVS Novartis
$91.58 /

-0.16 (-0.17%)

JNJ Johnson & Johnson
$177.19 /

-0.06 (-0.03%)

ISEE Iveric bio
$21.23 /

+0.35 (+1.68%)

APLS Apellis
$50.25 /

+2.575 (+5.40%)

Hot Stocks
Fiesta Restaurant names Dirk Montgomery as interim CEO » 17:22
12/08/22
12/08
17:22
12/08/22
17:22
FRGI

Fiesta Restaurant

$6.53 /

+0.145 (+2.27%)

Fiesta Restaurant…

Fiesta Restaurant "announced that Richard "Rich" Stockinger has stepped down from his role as the company's CEO and President to pursue other interests, effective immediately. Dirk Montgomery, Fiesta's CFO since 2019, will serve as interim CEO while the company searches for a permanent chief executive."

ShowHide Related Items >><<
FRGI Fiesta Restaurant
$6.53 /

+0.145 (+2.27%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.